Abstract
Eyebright (Euphrasia rostkoviana Hayne) is a medicinal plant belonging to the Orobanchaceae family. Extracts such as decoctions of Euphrasia have long been used for the treatment of inflamed eyes, conjunctivitis, stye and blepharitis. GC-MS and HPLC-APCI-MSn analyses revealed the presence of five homologous acetyl monoacylglycerols of 3-hydroxyfatty acids (C14-C18) in CH2Cl2 extracts of E. rostkoviana. These compounds were named euphrasianins A-E, being members of a novel class of lipid constituents. For structure verification, a three-step total synthesis of one homologue (euphrasianin A) was performed which was characterized by 1D- and 2D-NMR. After alkaline hydrolysis of an E. rostkoviana CH2Cl2 extract and methylation with BF3/MeOH the 3-hydroxy fatty acid methylesters thus obtained, were analyzed by chiral GC. By comparison with reference compounds the absolute configuration was found to be 'R'. Thus, the novel compounds were identified as 1-O-acetyl-3-[(3R)hydroxyfatty acid]-glycerols. While euphrasianins A and C were predominant in E. rostkoviana, another species, i.e. E. tetraquetra (seacliff eyebright), only revealed the occurrence of euphrasianins C and E, thus indicating that these target compounds may be utilized as chemotaxonomic markers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
